2020 Acura ILX
2.4 L • I4 • 201 hp • FWD • AT
19UDE2F37LA004837
Sales history: 1
Highlights
Condition
Run and drive
Seller
Insurance • State Farm Insurance
Key included
Yes
Docs
Good
History
1 record
Drive
2.4 L • I4 • 201 hp • FWD • AT
Odometer
50,527 mi ≈ 81,315 km
Primary damage
Front end
Secondary damage
Side
Docs
TX • Cert Title
Extra
Auction
VIN
19UDE2F37LA004837
Lot number
67992955
Copart
Sale status
Sold by Buy now
Seller type
Insurance
Seller
State Farm Insurance
Location
Dallas, TX
Description
Fuel type
Gasoline
Body color
White
Body type
Sedan
Generation
DE1, DE2, DE3
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
2020 Acura ILX • 2.4 L • I4 • 201 hp • FWD • Automatic • Copart Lot: 67992955 • VIN: 19UDE2F37LA004837
Find out more about this 2020 Acura ILX, available at the Copart salvage car auction as lot 67992955 in Dallas, TX. This car has Front end main damage. It is listed with Run and drive start condition code. Odometer shows 50,527 mi. This White Acura ILX Sedan is equipped with Gasoline 2.4 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for 19UDE2F37LA004837 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
